Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Successful Treatment with Rituximab and Immunoadsorption for an Auto-Antibody Induced Bile Salt Export Pump Deficiency in a Liver Transplanted Patient

  • Quintero, Jesus (Pediatric Hepatology and Liver Transplantation Unit, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona) ;
  • Juamperez, Javier (Pediatric Hepatology and Liver Transplantation Unit, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona) ;
  • Gonzales, Emmanuel (Inserm Unite Mixte de Recherche 1193, Universite Paris-Saclay) ;
  • Julio, Ecaterina (Pediatric Hepatology and Liver Transplantation Unit, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona) ;
  • Mercadal-Hally, Maria (Pediatric Hepatology and Liver Transplantation Unit, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona) ;
  • Collado-Hilly, Mauricette (Inserm Unite Mixte de Recherche 1193, Universite Paris-Saclay) ;
  • Marin-Sanchez, Ana (Department of Immunology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona) ;
  • Charco, Ramon (Department of HPB Surgery and Trasplant, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona)
  • Received : 2019.07.04
  • Accepted : 2019.12.12
  • Published : 2020.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

We present an 8 years old girl who was diagnosed at 6 months of age of Progressive Familial Intrahepatic Cholestasis type 2. Although liver transplantation (LT) was classically considered curative for these patients, cholestasis recurrence with normal gamma-glutamyl transpeptidase (GGT), mediated by anti-bile salt export pump (BSEP) antibodies after LT (auto-antibody Induced BSEP Deficiency, AIBD) has been recently reported. Our patient underwent LT at 14 months. During her evolution, patient presented three episodes of acute rejection. Seven years after the LT, the patient presented pruritus with cholestasis and elevation of liver enzymes with persistent normal GGT. Liver biopsy showed intrahepatic cholestasis and giant-cell transformation with very low BSEP activity. Auto-antibodies against BSEP were detected therefore an AIBD was diagnosed. She was treated with Rituximab and immunoadsorption with resolution of the AIBD. As a complication of the treatment she developed a pneumocystis infection successfully treated with corticoids, cotrimoxazol and anidulafungin.

Keywords

References

  1. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998;20:233-8. https://doi.org/10.1038/3034
  2. Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerova D, Rayner A, Dutton L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008;134:1203-14. https://doi.org/10.1053/j.gastro.2008.01.038
  3. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009;4:1. https://doi.org/10.1186/1750-1172-4-1
  4. Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999;117:1370-9. https://doi.org/10.1016/S0016-5085(99)70287-8
  5. Alissa FT, Jaffe R, Shneider BL. Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 2008;46:241-52. https://doi.org/10.1097/MPG.0b013e3181596060
  6. Jara P, Hierro L, Martinez-Fernandez P, Alvarez-Doforno R, Yanez F, Diaz MC, et al. Recurrence of bile salt export pump deficiency after liver transplantation. N Engl J Med 2009;361:1359-67. https://doi.org/10.1056/NEJMoa0901075
  7. Maggiore G, Gonzales E, Sciveres M, Redon MJ, Grosse B, Stieger B, et al. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2. J Hepatol 2010;53:981-6. https://doi.org/10.1016/j.jhep.2010.05.025
  8. Keitel V, Burdelski M, Warskulat U, Kuhlkamp T, Keppler D, Haussinger D, et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 2005;41:1160-72. https://doi.org/10.1002/hep.20682
  9. Keitel V, Burdelski M, Vojnisek Z, Schmitt L, Haussinger D, Kubitz R. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis. Hepatology 2009;50:510-7. https://doi.org/10.1002/hep.23083
  10. Davit-Spraul A, Fabre M, Branchereau S, Baussan C, Gonzales E, Stieger B, et al. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 2010;51:1645-55. https://doi.org/10.1002/hep.23539
  11. Cassio D, Macias RI, Grosse B, Marin JJ, Monte MJ. Expression, localization, and inducibility by bile acids of hepatobiliary transporters in the new polarized rat hepatic cell lines, Can 3-1 and Can 10. Cell Tissue Res 2007;330:447-60. https://doi.org/10.1007/s00441-007-0494-3
  12. Gonzales E, Grosse B, Schuller B, Davit-Spraul A, Conti F, Guettier C, et al. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate. Hepatology 2015;62:558-66. https://doi.org/10.1002/hep.27767
  13. Tu GW, Ju MJ, Xu M, Rong RM, He YZ, Xue ZG, et al. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients. Nephrology (Carlton) 2013;18:736-42. https://doi.org/10.1111/nep.12133
  14. Kubitz R, Droge C, Kluge S, Stross C, Walter N, Keitel V, et al. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis. Clin Rev Allergy Immunol 2015;48:273-84. https://doi.org/10.1007/s12016-014-8457-4
  15. Martin-Garrido I, Carmona EM, Specks U, Limper AH. Pneumocystis pneumonia in patients treated with rituximab. Chest 2013;144:258-65. https://doi.org/10.1378/chest.12-0477